Michael Gelband’s Enfusion, Inc. ENFN Stock Holding History

Michael Gelband’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,425	Closed	-$796K	–	2085
2025 Q1	$796K	Buy	71,425 +40,037	+128%	+$443K	0.01%	980
2024 Q4	$323K	Sell	31,388 -90,779	-74%	-$877K	﹤0.01%	1257
2024 Q3	$1.16M	Buy	+122,167	New	+$1.05M	0.01%	929
2024 Q2	–	Sell	-28,926	Closed	-$268K	–	2078
2024 Q1	$268K	Buy	+28,926	New	+$255K	﹤0.01%	1288
2023 Q3	–	Sell	-12,357	Closed	-$139K	–	2234
2023 Q2	$139K	Sell	12,357 -71,793	-85%	-$637K	﹤0.01%	1728
2023 Q1	$884K	Buy	84,150 +38,993	+86%	+$430K	0.01%	1181
2022 Q4	$437K	Buy	45,157 +33,273	+280%	+$375K	0.01%	1225
2022 Q3	$147K	Buy	+11,884	New	+$145K	﹤0.01%	1693

Other funds holding ENFN

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Michael Gelband's ENFN Position: Q2 2025 in Review

Michael Gelband sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 71,425 shares — an estimated $796K sold.

Michael Gelband first reported a position in ENFN in Q3 2022 and held it in 8 quarters. The position peaked at $1.16M in Q3 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Michael Gelband reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Michael Gelband sold 71,425 Enfusion, Inc. shares in Q2 2025, an estimated $796K.
Michael Gelband first reported a position in Enfusion, Inc. in Q3 2022 and held it in 8 quarters.
Michael Gelband's Enfusion, Inc. position peaked at $1.16M in Q3 2024.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.